Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
ICD-10 G13.8 is a billable code used to indicate a diagnosis of systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere.
G13.8 refers to systemic atrophy of the central nervous system that occurs as a consequence of various hereditary and degenerative diseases not specifically classified elsewhere. This includes conditions such as Huntington's disease, various forms of ataxia, and motor neuron diseases. These disorders are characterized by progressive degeneration of neurons, leading to significant neurological deficits. Huntington's disease, for instance, is a genetic disorder that causes the progressive breakdown of nerve cells in the brain, resulting in movement disorders, cognitive decline, and psychiatric symptoms. Ataxias, which can be hereditary or acquired, lead to coordination and balance issues due to cerebellar degeneration. Motor neuron diseases, such as amyotrophic lateral sclerosis (ALS), result in the degeneration of motor neurons, leading to muscle weakness and atrophy. The clinical presentation of G13.8 can vary widely depending on the underlying disease, but it generally involves a combination of motor, cognitive, and behavioral symptoms, necessitating a multidisciplinary approach for management and care.
Comprehensive neurological assessments, including imaging and genetic testing results.
Diagnosis and management of patients with hereditary ataxias or motor neuron diseases.
Ensure detailed documentation of neurological deficits and progression over time.
Family history, genetic testing results, and counseling notes.
Evaluation of patients with suspected hereditary neurological disorders.
Documenting the inheritance pattern and implications for family members.
Used for follow-up visits for patients with systemic atrophy due to underlying neurological conditions.
Detailed history and examination notes, including assessment of neurological deficits.
Neurologists should document the progression of symptoms and any changes in treatment plans.
G13.8 should be used when systemic atrophy of the central nervous system is documented as a result of other diseases classified elsewhere, and the underlying condition is clearly identified.
